Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Oruka Therapeutics, Inc. (ORKA) Insider Trading

17 open-market trades reported since Aug 14, 2026: 0 purchases worth $0 and 17 sales worth $22.0M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Paul T. QuinlanGeneral Counsel0$04$7.38MOct 20, 2026
Joana GoncalvesChief Medical Officer0$03$2.04MOct 15, 2026
Arjun AgarwalPresident0$05$2.85MOct 13, 2026
Lawrence Otto KleinCEO0$03$9.21MOct 2, 2026
Laura Lee SandlerCOO0$02$546KSep 15, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

ORKA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 20Oct 20Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL10b5-19,00078.53$707K−23%Form 4 ↗
Oct 15Oct 15Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,00074.81$524K−18%Form 4 ↗
Oct 13Oct 12Arjun AgarwalPresidentPresident▼ SELL10b5-19,99980.60$806K−41%Form 4 ↗
Oct 2Oct 1Lawrence Otto KleinCEOCEO▼ SELL10b5-125,00083.62$2.09M−2.6%Form 4 ↗
Sep 21Sep 21Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL10b5-110,00093.64$936K−25%Form 4 ↗
Sep 21Sep 21Arjun AgarwalPresidentPresident▼ SELL10b5-153395.75$51K−3.6%Form 4 ↗
Sep 15Sep 11Arjun AgarwalPresidentPresident▼ SELL10b5-19,45992.23$872K−38%Form 4 ↗
Sep 15Sep 15Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,94792.38$734K−20%Form 4 ↗
Sep 15Sep 15Lawrence Otto KleinCEOCEO▼ SELL2,45295.71$235K−0.3%Form 4 ↗
Sep 15Sep 15Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL1,03995.71$99K−3.3%Form 4 ↗
Sep 15Sep 15Laura Lee SandlerCOOCOO▼ SELL90695.71$87K−0.4%Form 4 ↗
Sep 15Sep 15Arjun AgarwalPresidentPresident▼ SELL10b5-156095.71$54K−3.7%Form 4 ↗
Sep 1Sep 1Lawrence Otto KleinCEOCEO▼ SELL10b5-175,00091.83$6.89M−7.5%Form 4 ↗
Sep 1Sep 1Laura Lee SandlerCOOCOO▼ SELL10b5-15,00091.82$459K−2.1%Form 4 ↗
Aug 17Aug 17Joana GoncalvesChief Medical OfficerChief Medical Officer▼ SELL10b5-17,000111.84$783K−18%Form 4 ↗
Aug 14Aug 14Paul T. QuinlanGeneral CounselGeneral Counsel▼ SELL10b5-152,000108.49$5.64M−63%Form 4 ↗
Aug 14Aug 13Arjun AgarwalPresidentPresident▼ SELL10b5-110,000106.66$1.07M−40%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings